Richard S. Finn, Masafumi Ikeda, Andrew X. Zhu, Max W. Sung, Ari D. Baron, Masatoshi Kudo, Takuji Okusaka, Masahiro Kobayashi, Hiromitsu Kumada, Shuichi Kaneko, et al. Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma. Journal of Clinical Oncology. 2020. 38. 26. 2960-2970
Mami Yasukawa, Yoshinari Ando, Taro Yamashita, Yoko Matsuda, Shisako Shoji, Masaki Suimye Morioka, Hideya Kawaji, Kumiko Shiozawa, Mitsuhiro Machitani, Takaya Abe, et al. CDK1 dependent phosphorylation of hTERT contributes to cancer progression. Nature communications. 2020. 11. 1. 1557-1557
Toshikatsu Tamai, Eishiro Mizukoshi, Masashi Kumagai, Takeshi Terashima, Noriho Iida, Masaaki Kitahara, Tetsuro Shimakami, Kazuya Kitamura, Kuniaki Arai, Taro Yamashita, et al. A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma. Scientific reports. 2020. 10. 1. 4021-4021
Yumie Takeshita, Takehiro Kanamori, Takeo Tanaka, Yuka Kaikoi, Yuki Kita, Noboru Takata, Noriho Iida, Kuniaki Arai, Tatsuya Yamashita, Kenichi Harada, et al. Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2020. 11. 2. 549-560